(July 28, 2016, 9:29 AM EDT) -- NEW YORK — Shareholders on July 25 filed a notice of appeal in a securities class action lawsuit against a pharmaceutical company and its former CEO, seeking Second Circuit U.S. Court of Appeals review of a federal judge’s ruling dismissing the action for failure to plead an actionable misrepresentation, scienter or loss causation (In re Sanofi Securities Litigation, No. 16-2573, 2nd Cir.)....